Molecular Recognition of Small Molecules by Rho-associated Kinase.
dc.contributor.author | Mishra, Lauren Dixon | en_US |
dc.date.accessioned | 2014-01-16T20:41:51Z | |
dc.date.available | NO_RESTRICTION | en_US |
dc.date.available | 2014-01-16T20:41:51Z | |
dc.date.issued | 2013 | en_US |
dc.date.submitted | 2013 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/102462 | |
dc.description.abstract | Rho-associated coiled-coil containing protein kinase (or ROCK) is the first known effector of the Rho GTPase family of proteins, which are responsible for processes such as adhesion, motility, proliferation, differentiation, and apoptosis. ROCK is one of the six clinically-validated kinase drug targets and its inhibition has been suggested as a potential therapeutic mode of action to treat a diverse array of diseases including cancer and autoimmunity. BZD-29 is a 1,4-benzodiazepine-2,5-dione with demonstrated attenuation of disease in the Schistosoma mansoni model of pulmonary inflammation and no general toxicity in rodents. Target identification and validation along with mechanism of action studies have demonstrated that BZD-29 is an ATP-competitive inhibitor of ROCKII. Although high resolution crystal structures exist for both of the two known ROCK isoforms, the molecular contacts necessary for potency and selectivity among the ROCK enzymes remain a topic of research and debate. This thesis describes the design, synthesis, and analysis of a series of analogs of BZD-29, designed to probe and optimize the structural features important for potent inhibition and selectivity for ROCKII. These efforts have resulted in the development of a highly stereoselective synthetic route for the production of chiral 1,4-benzodiazepine-2,5-diones, the design of inhibitors with 110-fold potency over BZD-29 and 10-fold potency over Fasudil, and the establishment of highly successful structure activity relationship models and computational models for use in future analog design. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | Lead Optimization | en_US |
dc.title | Molecular Recognition of Small Molecules by Rho-associated Kinase. | en_US |
dc.type | Thesis | en_US |
dc.description.thesisdegreename | PhD | en_US |
dc.description.thesisdegreediscipline | Medicinal Chemistry | en_US |
dc.description.thesisdegreegrantor | University of Michigan, Horace H. Rackham School of Graduate Studies | en_US |
dc.contributor.committeemember | Glick, Gary D. | en_US |
dc.contributor.committeemember | Soellner, Matthew Bryan | en_US |
dc.contributor.committeemember | Larsen, Scott D. | en_US |
dc.contributor.committeemember | Mapp, Anna K. | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/102462/1/laurenkd_1.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/102462/2/laurenkd_2.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/102462/3/laurenkd_3.pdf | |
dc.owningcollname | Dissertations and Theses (Ph.D. and Master's) |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.